Yue Xu - Publications

Shengjiang Xiexin decoction combined with vancomycin for Clostridioides difficile infection: impact of vancomycin dose-reduction strategy on gut microbiota homeostasis and recurrence risk.

Journal: Frontiers in cellular and infection microbiology

Published: November 05, 2025

Mesenchymal stem cells-derived miR-143-3p attenuate acute kidney injury by suppressing TAK1-Driven necroptosis.

Journal: Biochemical and biophysical research communications

Published: April 25, 2025

Ultrasound-guided renal subcapsular transplantation of mesenchymal stem cells for treatment of acute kidney injury in a minipig model: safety and efficacy evaluation.

Journal: Stem cell research & therapy

Published: September 08, 2024

Local Renal Treatments for Acute Kidney Injury: A Review of Current Progress and Future Translational Opportunities.

Journal: Journal of endourology

Published: February 22, 2024

Microbial bile acid metabolite ameliorates mycophenolate mofetil-induced gastrointestinal toxicity through vitamin D3 receptor.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 27, 2023

Comprehensive molecular and cellular characterization of endoplasmic reticulum stress-related key genes in renal ischemia/reperfusion injury.

Journal: Frontiers in immunology

Published: November 19, 2023

An autophagy-associated diagnostic signature based on peripheral blood for antibody-mediated rejection in renal transplantation.

Journal: Transplant immunology

Published: October 04, 2023

Single-cell profiling reveals distinct immune response landscapes in tuberculous pleural effusion and non-TPE.

Journal: Frontiers in immunology

Published: March 22, 2023

Single-cell dissection of cellular and molecular features underlying mesenchymal stem cell therapy in ischemic acute kidney injury.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 17, 2023

Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 19, 2019

SDF‑1/CXCR4 induces epithelial‑mesenchymal transition through activation of the Wnt/β‑catenin signaling pathway in rat chronic allograft nephropathy.

Journal: Molecular medicine reports

Published: September 18, 2018

CXC Chemokine Receptor 4 (CXCR4) Antagonist, a Novel Pathway to Prevent Chronic Allograft Nephropathy.

Journal: Annals of transplantation

Published: November 26, 2016